Clinical Trial Update: Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing intravitreal aflibercept monotherapy to aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Association for Innovation and Biomedical Research on Light and Image | Conditions: Polypoidal Choroidal Vasculopathy | Phase 4 | Status: COMPLETED